Ab&B Bio-Tech (2627) Announces Independent Director Resignation and Nominates Successor

Bulletin Express
2025/12/04

Ab&B Bio-Tech CO., LTD. JS (Stock Code: 2627) has announced the resignation of Independent Non-Executive Director Ms. Li Xiaoqing. She will also step down as chairperson of the Audit Committee and as a member of both the Remuneration and Appraisal Committee and the Nomination Committee, citing personal endeavors. Her resignation takes effect once a new independent non-executive director is elected at the company’s second extraordinary general meeting of 2025.

The board has nominated Mr. Li Jianjun as a candidate for independent non-executive director of the second session of the board, pending approval at the same EGM. Mr. Li, aged 57, has over three decades of experience in accounting and tax services, having served in various tax-bureau, accounting, and audit roles. He holds an MBA from the Tsinghua University–Bangor University joint program and from China Europe International Business School, and is both a Certified Tax Advisor and a Certified Public Accountant in the People’s Republic of China.

With Mr. Li’s nomination, he will become chairperson of the Audit Committee and a member of the Remuneration and Appraisal Committee upon formal appointment. Additional board committee changes will take effect on the date he assumes the role of independent non-executive director, including updates to the membership of the Nomination Committee.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10